Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Effect Size Analysis of Cipaglucosidase Alfa Plus Miglustat Versus Alglucosidase Alfa in ERT-experienced Adults with Late-onset Pompe Disease in PROPEL

              Author:Kushlaf, Hani   Bratkovic, Drago   Byrne, Barry   Claeys, Kristl   Diaz-Manera, Jordi   Dimachkie, Mazen   Kishnani, Priya   Roberts, Mark   Toscano, Antonio   Castelli, Jeff   Holdbrook, Frederick   Das, Sheela   Wasfi, Yasmine   Schoser, Benedikt   Mozaffar, Tahseen   

              Session Name:S21: Inherited Myopathies and Neuropathies: New Therapeutic Approaches and Observations  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S21.003  

              Author Institution:University of Cincinnati, Cincinnati, OH  PARC Research Clinic, Royal Adelaide Hospital, Adelaide, SA, Australia  University of Florida, Gainesville, FL  Department of Neurology, University Hospitals Leuven, and Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, KU Leuven, Leuven, Belgium  John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle, United Kingdom  Department of Neurology, University of Kansas Medical Center, Kansas City, KS  Duke University Medical Center, Durham, NC  Salford Royal NHS Foundation Trust, Salford, United Kingdom  ERN-NMD Center for Neuromuscular Disorders of Messina, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy  Amicus Therapeutics, Inc., Princeton, NJ  Friedrich-Baur-Institute at the Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany  Department of Neurology, University of California, Irvine, CA